United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

colonis pharma ltd - acetylcysteine - powder - 200mg

United States - English - NLM (National Library of Medicine)

cumberland pharmaceuticals inc. - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine 200 mg in 1 ml - acetadote is indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen in patients with acute ingestion or from repeated supratherapeutic ingestion (rsi). acetadote is contraindicated in patients with a previous hypersensitivity reaction to acetylcysteine [see warnings and precautions (5.1)] . risk summary limited published case reports and case series of pregnant women exposed to acetylcysteine during various trimesters are not sufficient to inform any drug associated risk. delaying treatment of acetaminophen overdose may increase the risk of maternal or fetal morbidity and mortality [see clinical considerations]. reproduction studies in rats and rabbits following oral administration of acetylcysteine during the period of organogenesis at doses similar to the total intravenous dose (based on the body surface area) did not cause any adverse effects to the fetus. the estimated background risk of major birth defects and miscarriage for the indicated po

Australia - English - Department of Health (Therapeutic Goods Administration)

phebra pty ltd - acetylcysteine, quantity: 6 g - injection - excipient ingredients: sodium hydroxide; water for injections - as an antidote for paracetamol poisoning: acetadote injection is indicated in the treatment of paracetamol overdose to protect against hepatoxicity.

United States - English - NLM (National Library of Medicine)

exela pharma sciences, llc - acetylcysteine (unii: wyq7n0bpyc) (acetylcysteine - unii:wyq7n0bpyc) - acetylcysteine solution, usp is indicated as adjuvant therapy for patients with abnormal, viscid, or inspissated mucous secretions in such conditions as: acetylcysteine is contraindicated in those patients who are sensitive to it. acetylcysteine solution, usp administered orally, is indicated as an antidote to prevent or lessen hepatic injury which may occur following the ingestion of a potentially hepatotoxic quantity of acetaminophen. it is essential to initiate treatment as soon as possible after the overdose and, in any case, within 24 hours of ingestion. there are no contraindications to oral administration of acetylcysteine in the treatment of acetaminophen overdose.

Malta - English - Medicines Authority

central procurement & supplies unit - acetylcysteine - concentrate for solution for infusion - acetylcysteine 200 milligram(s)/millilitre - all other therapeutic products

Malta - English - Medicines Authority

aurum pharmaceuticals limited bampton road, harold hill, romford essex, rm3 8ug, united kingdom - acetylcysteine - solution for infusion - acetylcysteine 200 mg/ml - all other therapeutic products

Malta - English - Medicines Authority

p & d pharmaceuticals limited 38 woolmer way, bordon hampshire gu35 9qf, united kingdom - acetylcysteine - concentrate for solution for infusion - acetylcysteine 200 mg/ml - all other therapeutic products

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

martindale pharmaceuticals ltd - acetylcysteine - solution for infusion - 200mg/1ml

Singapore - English - HSA (Health Sciences Authority)

sandoz singapore pte. ltd. - acetylcysteine - tablet, effervescent - 600mg - acetylcysteine 600mg

Israel - English - Ministry of Health

megapharm ltd - acetylcysteine - tablets effervescent - acetylcysteine 200 mg - acetylcysteine - acetylcysteine - mucolytic in respiratory tract disorders where reduction of sputum viscosity is required.